BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Alterity Therapeutics Ltd.

Headquarters: Melbourne, Victoria, Australia
Year Founded: 1997
Status: Public
Industry Sector: HealthTechnology
CEO: David A. Stamler, MD
Number Of Employees: 10
Enterprise Value: $1,411,091
PE Ratio: -2.75
Exchange/Ticker 1: ASX:ATH
Exchange/Ticker 2: NASDAQ:ATHE
Latest Market Cap: $64,841,421

BioCentury | Mar 17, 2025
Product Development

Lundbeck’s next chapter: from psychiatry to rare neuro

Leaving past limitations behind, Danish pharma widens its technology aperture to brain shuttles, AI and more  
BioCentury | Dec 23, 2023
Management Tracks

Pacira names Lee CEO, Hastings chair

Plus: CRISPR’s CMO to depart and a new CFO for Alterity
Items per page:
1 - 2 of 2